TIAA CREF Investment Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$6.34M Buy
255,289
+90,604
+55% +$2.25M ﹤0.01% 1292
2018
Q4
$2.96M Sell
164,685
-7,881
-5% -$142K ﹤0.01% 1717
2018
Q3
$5.07M Sell
172,566
-7,848
-4% -$230K ﹤0.01% 1559
2018
Q2
$8.2M Buy
180,414
+8,352
+5% +$380K 0.01% 1278
2018
Q1
$9.09M Sell
172,062
-138,434
-45% -$7.31M 0.01% 1177
2017
Q4
$21.1M Sell
310,496
-12,127
-4% -$825K 0.01% 767
2017
Q3
$26.6M Buy
322,623
+3,245
+1% +$267K 0.02% 636
2017
Q2
$29.9M Buy
319,378
+4,925
+2% +$461K 0.02% 601
2017
Q1
$20M Buy
314,453
+41,383
+15% +$2.63M 0.01% 752
2016
Q4
$12.1M Buy
273,070
+133,257
+95% +$5.92M 0.01% 1001
2016
Q3
$5.04K Buy
139,813
+13,320
+11% +$480 ﹤0.01% 1611
2016
Q2
$1.74M Buy
126,493
+13,873
+12% +$190K ﹤0.01% 2213
2016
Q1
$2.16M Buy
112,620
+3,600
+3% +$69.1K ﹤0.01% 2023
2015
Q4
$3.82M Sell
109,020
-3,191
-3% -$112K ﹤0.01% 1748
2015
Q3
$10.3M Buy
112,211
+12,674
+13% +$1.17M 0.01% 1029
2015
Q2
$8.75M Buy
99,537
+1,246
+1% +$109K 0.01% 1250
2015
Q1
$7.3M Sell
98,291
-10,975
-10% -$815K 0.01% 1370
2014
Q4
$6.12M Sell
109,266
-17,040
-13% -$954K ﹤0.01% 1478
2014
Q3
$5.73M Sell
126,306
-1,834
-1% -$83.2K ﹤0.01% 1508
2014
Q2
$5.31M Buy
128,140
+36,522
+40% +$1.51M ﹤0.01% 1654
2014
Q1
$6.35M Sell
91,618
-1,322
-1% -$91.6K ﹤0.01% 1446
2013
Q4
$5.6M Buy
92,940
+13,994
+18% +$843K ﹤0.01% 1558
2013
Q3
$4.8M Buy
78,946
+11,976
+18% +$728K ﹤0.01% 1609
2013
Q2
$4.49M Buy
+66,970
New +$4.49M ﹤0.01% 1610